Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 14 Mar 23 EFFECT Notice of effectiveness
- 9 Mar 23 POS AM Prospectus update (post-effective amendment)
- 20 Oct 20 424B3 Prospectus supplement
- 20 Oct 20 EFFECT Notice of effectiveness
- 30 Sep 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
28 Aug 20 S-4 Registration of securities issued in business combination transactions
FSTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Registration Statement on Form S-4 of Spring Bank Pharmaceuticals, Inc. of our report dated February 14, 2020, relating to the consolidated financial statements of Spring Bank Pharmaceuticals, Inc. and its subsidiaries, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ RSM US LLP
Boston, Massachusetts
August 28, 2020